
KI-301670 is a novel мощный, specific NUAK1 ингибитор, disturbs NUAK1 signaling by targeting its ATP связывание site, effectively inhibits the PI3K/AKT pathway in pancreatic cancer cells.
KI-301670 is a novel potent, specific NUAK1 inhibitor, disturbs NUAK1 signaling by targeting its ATP binding site, effectively inhibits the PI3K/AKT pathway in pancreatic cancer cells.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.